You-Hua Huang1, Qiang Xu1, Tao Shen1, Jian-Ke Li1, Jing-Yu Sheng2, Hong-Jian Shi3. 1. Department of Radiology, Wujin Hospital, Jiangsu University, Changzhou, China. 2. Department of Cardiology, Wujin Hospital, Jiangsu University, Changzhou, China. 3. Department of Radiology, Wujin Hospital, Jiangsu University, Changzhou, China. shihongjian@sina.com.
Abstract
BACKGROUND: Even with drug-eluting stents, the risk of in-stent restenosis (ISR) remains high. The goal of this study was to investigate the use of an endothelial progenitor cell (EPC) capture stent plus regional EPC transplantation to reduce the ISR rate. METHODS: Endothelial progenitor cell capture stents were fabricated using fibrin gel and anti-CD34 plus anti-VEGFR-2 dual antibodies. Twenty male New Zealand white rabbits established as an atherosclerotic model were randomly divided into two groups: group 1 (n = 10), in which EPC capture stents were deployed into the right iliac artery; and group 2 (n = 10), in which sirolimus-eluting stents were placed. In both groups, EPCs were transplanted into target vessels beyond the stents, with outflow blocked. Radiologic-pathologic correlation outcomes were reviewed after 2 months. RESULTS: The technical success rate of EPC capture stent placement plus EPC transplantation was 100%. The ISR rate in group 1 was lower than in group 2 (1/10 vs. 4/10; p > 0.05). Minimal luminal diameters were larger in group 1 than in group 2 (computed tomographic angiography, 1.85 ± 0.15 mm vs. 1.50 ± 0.20 mm; duplex ultrasound, 1.90 ± 0.10 mm vs. 1.70 ± 0.30 mm; p > 0.05). Transplanted EPCs were tracked positively only in group 1. Pathologic analysis demonstrated neointimal hyperplasia thickness of 0.21 ± 0.09 mm in group 1 vs. 0.11 ± 0.07 mm in group 2 (p < 0.05). CONCLUSION: Endothelial progenitor cell capture stent placement plus local EPC transplant decreases the ISR rate through thrombosis reduction rather than through neointimal hyperplasia inhibition.
BACKGROUND: Even with drug-eluting stents, the risk of in-stent restenosis (ISR) remains high. The goal of this study was to investigate the use of an endothelial progenitor cell (EPC) capture stent plus regional EPC transplantation to reduce the ISR rate. METHODS: Endothelial progenitor cell capture stents were fabricated using fibrin gel and anti-CD34 plus anti-VEGFR-2 dual antibodies. Twenty male New Zealand white rabbits established as an atherosclerotic model were randomly divided into two groups: group 1 (n = 10), in which EPC capture stents were deployed into the right iliac artery; and group 2 (n = 10), in which sirolimus-eluting stents were placed. In both groups, EPCs were transplanted into target vessels beyond the stents, with outflow blocked. Radiologic-pathologic correlation outcomes were reviewed after 2 months. RESULTS: The technical success rate of EPC capture stent placement plus EPC transplantation was 100%. The ISR rate in group 1 was lower than in group 2 (1/10 vs. 4/10; p > 0.05). Minimal luminal diameters were larger in group 1 than in group 2 (computed tomographic angiography, 1.85 ± 0.15 mm vs. 1.50 ± 0.20 mm; duplex ultrasound, 1.90 ± 0.10 mm vs. 1.70 ± 0.30 mm; p > 0.05). Transplanted EPCs were tracked positively only in group 1. Pathologic analysis demonstrated neointimal hyperplasia thickness of 0.21 ± 0.09 mm in group 1 vs. 0.11 ± 0.07 mm in group 2 (p < 0.05). CONCLUSION: Endothelial progenitor cell capture stent placement plus local EPC transplant decreases the ISR rate through thrombosis reduction rather than through neointimal hyperplasia inhibition.
Authors: John Cosgrave; Pierfrancesco Agostoni; Lei Ge; Ioannis Iakovou; Alaide Chieffo; Giuseppe G L Biondi-Zoccai; Giuseppe M Sangiorgi; Matteo Montorfano; Iassen Michev; Flavio Airoldi; Mauro Carlino; Nicola Corvaja; Ermino Bonizzoni; Antonio Colombo Journal: Am J Cardiol Date: 2005-10-24 Impact factor: 2.778
Authors: Fernando Alfonso; María Jose Pérez-Vizcayno; Alberto Cárdenas; Bruno García del Blanco; Arturo García-Touchard; José Ramón López-Minguéz; Amparo Benedicto; Mónica Masotti; Javier Zueco; Andrés Iñiguez; Maite Velázquez; Raúl Moreno; Vicente Mainar; Antonio Domínguez; Francisco Pomar; Rafael Melgares; Fernando Rivero; Pilar Jiménez-Quevedo; Nieves Gonzalo; Cristina Fernández; Carlos Macaya Journal: J Am Coll Cardiol Date: 2015-07-07 Impact factor: 24.094
Authors: Gregg W Stone; Stephen G Ellis; Louis Cannon; J Tift Mann; Joel D Greenberg; Douglas Spriggs; Charles D O'Shaughnessy; Samuel DeMaio; Patrick Hall; Jeffrey J Popma; Joerg Koglin; Mary E Russell Journal: JAMA Date: 2005-09-14 Impact factor: 56.272
Authors: David R Holmes; Dean J Kereiakes; Scot Garg; Patrick W Serruys; Gregory J Dehmer; Stephen G Ellis; David O Williams; Takeshi Kimura; David J Moliterno Journal: J Am Coll Cardiol Date: 2010-10-19 Impact factor: 24.094
Authors: Vaishali V Inamdar; Emmett Fitzpatrick; Ivan Alferiev; Chandrasekaran Nagaswami; Lynn A Spruce; Hossein Fazelinia; George Bratinov; Steven H Seeholzer; Robert J Levy; Ilia Fishbein; Stanley J Stachelek Journal: Acta Biomater Date: 2020-01-11 Impact factor: 8.947